Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) FCF Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed FCF Margin for 8 consecutive years, with 966.37% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 191696.0% to 966.37% in Q3 2025 year-over-year; TTM through Sep 2025 was 1327.95%, a 77256.0% increase, with the full-year FY2024 number at 2230.24%, up 245189.0% from a year prior.
  • FCF Margin was 966.37% for Q3 2025 at Catheter Precision, up from 1070.28% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 574.8% in Q4 2021 to a low of 202450.0% in Q1 2021.
  • A 5-year average of 35028.57% and a median of 1941.61% in 2024 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: plummeted -20193537bps in 2021, then skyrocketed 11509021bps in 2023.
  • Catheter Precision's FCF Margin stood at 574.8% in 2021, then plummeted by -21005bps to 120160.0% in 2022, then surged by 99bps to 1489.84% in 2023, then plummeted by -30bps to 1941.61% in 2024, then soared by 50bps to 966.37% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's FCF Margin are 966.37% (Q3 2025), 1070.28% (Q2 2025), and 1641.96% (Q1 2025).